Long‐term efficacy and safety of zanubrutinib (ZANU) in relapsed/refractory marginal zone lymphoma (R/R MZL): final analysis of the MAGNOLIA (BGB‐3111‐214) trial von Trotman, J., Tedeschi, A., Hu, B., Linton, K. M., McKay, P., Leitch, S., Jin, J., Sun, M., Sobieraj‐Teague, M., Zinzani, P. L., Browett, P., Thieblemont, C., Liberati, A. M., Bachy, E., Cavallo, F., Costello, R., Iyengar, S., Marasca, R., Mociková, H., Kim, J. S., Talaulikar, D., Liang, Z., Xu, J., Tankersley, C., Delarue, R., Co, M., Opat, S.

Volltext

Prognostic significance of absolute lymphocyte count and lymphocyte subsets in lymphomas von Mociková, H

Volltext

Advanced stages of classical Hodgkin lymphoma – first-line treatment options von Móciková, Heidi

Volltext

SAFETY AND EFFICACY OF ZANUBRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA (MAGNOLIA PHASE 2 STUDY) von Trotman, J., Tedeschi, A., Linton, K., McKay, P., Hu, B., Chan, H., Jin, J., Sobieraj‐Teague, M., Zinzani, P. L., Coleman, M., Browett, P., Ke, X., Sun, M., Marcus, R., Portell, C., Thieblemont, C., Zhou, K., Liberati, A. M., Bachy, E., Cavallo, F., Costello, Rég., Iyengar, S., Marasca, R., Mociková, H., Kim, J. S., Talaulikar, D., Co, M., Zhou, W., Huang, J., Opat, S.

Volltext

The biological environment of Hodgkin's lymphoma and the role of the chemokine CCL17/TARC von Hnátková, M, Mociková, H, Trnený, M, Zivný, J

Volltext

Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL) von Janikova, A., Michalka, J., Chloupkova, R., Kopalova, N., Campr, V., Kamaradova, K., Kren, L., Belada, D., Benesova, K., Dlouha, J., Klener, P., Procházka, V., Mocikova, H., Duras, J., Trneny, M.

Volltext

Positron emission tomography at the end of first-line therapy and during follow-up in patients with Hodgkin lymphoma: a retrospective study von Mocikova, H., Obrtlikova, P., Vackova, B., Trneny, M.

Volltext

OUTCOMES OF THE TREATMENT AFTER ANTI‐CD19 CAR‐T THERAPY FAILURE IN PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA—ANALYSIS OF DATA FROM THE CZECH REPUBLIC von Sýkorová, A., Polgárová, K., Folber, F., Ďuraš, J., Móciková, H., Steinerová, K., Obr, A., Belada, D., Smolej, L., Trněný, M., Pytlík, R.

Volltext

BRENTUXIMAB VEDOTIN IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED CD30‐POSITIVE PERIPHERAL T‐CELL LYMPHOMAS: REAL‐WORLD DATA von Klanova, M., Sykorova, A., Janikova, A., Mocikova, H., Duras, J., Prochazka, V., Pukyova, J., Klener, P., Belada, D., Kopalova, N., Benesova, K., Campr, V., Blahovcova, P., Trneny, M.

Volltext

HOW WE ARE SUCCESSFUL IN THERAPY OF T‐CELL LYMPHOMA PATIENTS (≥70 YEARS). REAL‐WORDL ANALYSIS FROM THE CZECH LYMPHOMA STUDY GROUP REGISTRY (NIHIL) von Janikova, A., Klanova, M., Belada, D., Chloupkova, R., Campr, V., Kamaradova, K., Kopalova, N., Benesova, K., Prochazka, V., Mocikova, H., Duras, J., Trneny, M.

Volltext

ANALYSIS OF PATIENTS IN THE FIRST RELAPSE OR PROGRESSION OF T‐CELL LYMPHOMA. REAL WORLD DATA FROM CZECH LYMPHOMA STUDY GROUP REGISTRY (NIHIL) von Janikova, A., Belada, D., Klanova, M., Chloupkova, R., Kopalova, N., Campr, V., Kamaradova, K., Prochazka, V., Benesova, K., Mocikova, H., Duras, J., Trneny, M.

Volltext

Outcome of elderly patients with classical Hodgkin’s lymphoma von Sykorova, A., Mocikova, H., Lukasova, M., Koren, J., Stepankova, P., Prochazka, V., Belada, D., Klaskova, K., Gaherova, L., Chroust, K., Buresova, L., Markova, J.

Volltext

Phase 2 KEYNOTE‐B68 study: pembrolizumab every 6 weeks in relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL) or primary mediastinal B‐cell lymphoma (PMBCL) von McDonald, A., Verburgh, E., Gotti, M., Pinto, A., Zaucha, J., Ivanov, V., Melnichenko, V., Mocikova, H., Ozcan, M., Patti, C., Farias, J., Goncalves, I., Kuchkova, O., Mayer, J., Saydam, G., Tomassetti, S., Pathiraja, K., Ryland, K., Chakraborty, S., Jurczak, W.

Volltext

COGNITIVE IMPAIRMENT AFTER 6 AND 12 MONTHS OF HODGKIN LYMPHOMA TREATMENT von Mocikova, H., Gaherova, L., Fayette, D., Jurickova, V., Horacek, J., Kozak, T.

Volltext

PERIPHERAL T‐CELL LYMPHOMAS INVOLVING CENTRAL NERVOUS SYSTEM: A REPORT FROM THE CZECH LYMPHOMA STUDY GROUP REGISTRY von Mocikova, H., Pytlik, R., Benesova, K., Janikova, A., Duras, J., Sykorova, A., Steinerova, K., Prochazka, V., Campr, V., Belada, D., Dlouha, J., Trneny, M.

Volltext

DA‐EPOCH‐R VERSUS R‐CHOP IN HIGH RISK DLBCL PATIENTS: ANALYSIS OF THE CZECH LYMPHOMA STUDY GROUP (CLSG) von Šimkovič, M., Móciková, H., Ďuraš, J., Kamarádová, K., Štěpánková, P., Janíková, A., Michalka, J., Žák, P., Belada, D., Trněný, M.

Volltext

PREDICTIVE VALUE OF PRIMA‐PROGNOSTIC INDEX (PRIMA‐PI) IN FIRST RELAPSE OF FOLLICULAR LYMPHOMA von Ďuraš, J., Procházka, V., Belada, D., Janíková, A., Móciková, H., Kopečková, K., Hájek, R., Trněný, M.

Volltext

P676: LOW‐DOSE FCR COMPARED TO BR IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITHOUT TP53 ABERRATIONS: A REAL – WORLD RETROSPECTIVE ANALYSIS BY THE CZECH CL... von Smolej, L., Brychtová, Y., Cmunt, E., Oršulová, M., Vodárek, P., Dostál, M., Turcsányi, P., Urbanová, R., Panovská, A., Zuchnická, J., Mihályová, J., Lysák, D., Brejcha, M., Móciková, H., Klásková, K., Šimkovič, M., Špaček, M., Doubek, M.

Volltext

T‐CELL LYMPHOMA IN THE ELDERLY PATIENTS. WHO IS YOUNG, OLD, AND ELDERLY? von Janikova, A., Chloupkova, R., Klener, P., Benesova, K., Campr, V., Belada, D., Sykorova, A., Prochazka, V., Kopalova, N., Hamouzova, J., Pirnos, J., Duras, J., Mocikova, H., Trneny, M.

Volltext

IS IT RADIOTHERAPY NECESSARY FOR PRIMARY MEDIASTINAL B‐CELL LYMPHOMA (PMBL) PATIENTS ACHIEVING PET NEGATIVITY AFTER IMMUNOCHEMOTHERAPY? von Trneny, M., Polgarova, K., Janikova, A., Belada, D., Prochazka, V., Duras, J., Mocikova, H., Steinerova, K., Campr, V., Blahovcova, P., Petrova, M., Zogala, D., Ptacnik, V.

Volltext